- Home
- Coronavirus
- Sectors
- Topics
- HSJ Local
- Comment
- HSJ Knowledge
- Events
17 March 2021
8 April 2021
- Jobs
- Products & Services
- Subscribe
Close menu
- Home
- Coronavirus
- Sectors
- Topics
- HSJ Local
- Comment
-
HSJ Knowledge
- Back to parent navigation item
- HSJ Knowledge
- HSJ Partners
- Covid-19 Resources
- Health Check Podcast
- Immersive features
- Top leader lists
- Roundtables
- HSJ webinars
- Commissions and inquiries
- Supplement Archive
- HSJ Healthcare Partnership Awards
-
Channels and networks
- Back to parent navigation item
- Channels and networks
- Insight and influence
- Events
- Jobs
- Products & Services
- Subscribe
PCTs to fund controversial eye drugs
By Helen Mooney2008-01-31T09:00:00
Primary care trusts across Cheshire and Merseyside and Norfolk have agreed to fund two controversial treatments that can prevent patients with a serious eye condition from going blind.
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics
HSJ is part of Wilmington Healthcare Limited, Beechwood House, 2-3 Commercial Way, Christy Close, Southfields, Essex, SS15 6EF. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud